Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

نویسندگان

  • Fergus J Couch
  • Mia M Gaudet
  • Antonis C Antoniou
  • Susan J Ramus
  • Karoline B Kuchenbaecker
  • Penny Soucy
  • Jonathan Beesley
  • Xiaoqing Chen
  • Xianshu Wang
  • Tomas Kirchhoff
  • Lesley McGuffog
  • Daniel Barrowdale
  • Andrew Lee
  • Sue Healey
  • Olga M Sinilnikova
  • Irene L Andrulis
  • Hilmi Ozcelik
  • Anna Marie Mulligan
  • Mads Thomassen
  • Anne-Marie Gerdes
  • Uffe Birk Jensen
  • Anne-Bine Skytte
  • Torben A Kruse
  • Maria A Caligo
  • Anna von Wachenfeldt
  • Gisela Barbany-Bustinza
  • Niklas Loman
  • Maria Soller
  • Hans Ehrencrona
  • Per Karlsson
  • Katherine L Nathanson
  • Timothy R Rebbeck
  • Susan M Domchek
  • Ania Jakubowska
  • Jan Lubinski
  • Katarzyna Jaworska
  • Katarzyna Durda
  • Elzbieta Zlowocka
  • Tomasz Huzarski
  • Tomasz Byrski
  • Jacek Gronwald
  • Cezary Cybulski
  • Bohdan Górski
  • Ana Osorio
  • Mercedes Durán
  • María Isabel Tejada
  • Javier Benitez
  • Ute Hamann
  • Frans B L Hogervorst
  • Theo A van Os
  • Flora E van Leeuwen
  • Hanne E J Meijers-Heijboer
  • Juul Wijnen
  • Marinus J Blok
  • Marleen Kets
  • Maartje J Hooning
  • Rogier A Oldenburg
  • Margreet G E M Ausems
  • Susan Peock
  • Debra Frost
  • Steve D Ellis
  • Radka Platte
  • Elena Fineberg
  • D Gareth Evans
  • Chris Jacobs
  • Rosalind A Eeles
  • Julian Adlard
  • Rosemarie Davidson
  • Diana M Eccles
  • Trevor Cole
  • Jackie Cook
  • Joan Paterson
  • Carole Brewer
  • Fiona Douglas
  • Shirley V Hodgson
  • Patrick J Morrison
  • Lisa Walker
  • Mary E Porteous
  • M John Kennedy
  • Lucy E Side
  • Betsy Bove
  • Andrew K Godwin
  • Dominique Stoppa-Lyonnet
  • Marion Fassy-Colcombet
  • Laurent Castera
  • François Cornelis
  • Sylvie Mazoyer
  • Mélanie Léoné
  • Nadia Boutry-Kryza
  • Brigitte Bressac-de Paillerets
  • Olivier Caron
  • Pascal Pujol
  • Isabelle Coupier
  • Capucine Delnatte
  • Linda Akloul
  • Henry T Lynch
  • Carrie L Snyder
  • Saundra S Buys
  • Mary B Daly
  • Marybeth Terry
  • Wendy K Chung
  • Esther M John
  • Alexander Miron
  • Melissa C Southey
  • John L Hopper
  • David E Goldgar
  • Christian F Singer
  • Christine Rappaport
  • Muy-Kheng M Tea
  • Anneliese Fink-Retter
  • Thomas V O Hansen
  • Finn C Nielsen
  • Aðalgeir Arason
  • Joseph Vijai
  • Sohela Shah
  • Kara Sarrel
  • Mark E Robson
  • Marion Piedmonte
  • Kelly Phillips
  • Jack Basil
  • Wendy S Rubinstein
  • John Boggess
  • Katie Wakeley
  • Amanda Ewart-Toland
  • Marco Montagna
  • Simona Agata
  • Evgeny N Imyanitov
  • Claudine Isaacs
  • Ramunas Janavicius
  • Conxi Lazaro
  • Ignacio Blanco
  • Lidia Feliubadalo
  • Joan Brunet
  • Simon A Gayther
  • Paul P D Pharoah
  • Kunle O Odunsi
  • Beth Y Karlan
  • Christine S Walsh
  • Edith Olah
  • Soo Hwang Teo
  • Patricia A Ganz
  • Mary S Beattie
  • Elizabeth J van Rensburg
  • Cecelia M Dorfling
  • Orland Diez
  • Ava Kwong
  • Rita K Schmutzler
  • Barbara Wappenschmidt
  • Christoph Engel
  • Alfons Meindl
  • Nina Ditsch
  • Norbert Arnold
  • Simone Heidemann
  • Dieter Niederacher
  • Sabine Preisler-Adams
  • Dorothea Gadzicki
  • Raymonda Varon-Mateeva
  • Helmut Deissler
  • Andrea Gehrig
  • Christian Sutter
  • Karin Kast
  • Britta Fiebig
  • Wolfram Heinritz
  • Trinidad Caldes
  • Miguel de la Hoya
  • Taru A Muranen
  • Heli Nevanlinna
  • Marc D Tischkowitz
  • Amanda B Spurdle
  • Susan L Neuhausen
  • Yuan Chun Ding
  • Noralane M Lindor
  • Zachary Fredericksen
  • V Shane Pankratz
  • Paolo Peterlongo
  • Siranoush Manoukian
  • Bernard Peissel
  • Daniela Zaffaroni
  • Monica Barile
  • Loris Bernard
  • Alessandra Viel
  • Giuseppe Giannini
  • Liliana Varesco
  • Paolo Radice
  • Mark H Greene
  • Phuong L Mai
  • Douglas F Easton
  • Georgia Chenevix-Trench
  • Kenneth Offit
  • Jacques Simard
چکیده

BACKGROUND Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk factors for breast cancer among BRCA1 and BRCA2 mutation carriers, respectively. We explored associations with ovarian cancer and with breast cancer by tumor histopathology for these variants in mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). METHODS Genotyping data for 12,599 BRCA1 and 7,132 BRCA2 mutation carriers from 40 studies were combined. RESULTS We confirmed associations between rs8170 at 19p13.1 and breast cancer risk for BRCA1 mutation carriers [HR, 1.17; 95% confidence interval (CI), 1.07-1.27; P = 7.42 × 10(-4)] and between rs16917302 at ZNF365 (HR, 0.84; 95% CI, 0.73-0.97; P = 0.017) but not rs311499 at 20q13.3 (HR, 1.11; 95% CI, 0.94-1.31; P = 0.22) and breast cancer risk for BRCA2 mutation carriers. Analyses based on tumor histopathology showed that 19p13 variants were predominantly associated with estrogen receptor (ER)-negative breast cancer for both BRCA1 and BRCA2 mutation carriers, whereas rs16917302 at ZNF365 was mainly associated with ER-positive breast cancer for both BRCA1 and BRCA2 mutation carriers. We also found for the first time that rs67397200 at 19p13.1 was associated with an increased risk of ovarian cancer for BRCA1 (HR, 1.16; 95% CI, 1.05-1.29; P = 3.8 × 10(-4)) and BRCA2 mutation carriers (HR, 1.30; 95% CI, 1.10-1.52; P = 1.8 × 10(-3)). CONCLUSIONS 19p13.1 and ZNF365 are susceptibility loci for ovarian cancer and ER subtypes of breast cancer among BRCA1 and BRCA2 mutation carriers. IMPACT These findings can lead to an improved understanding of tumor development and may prove useful for breast and ovarian cancer risk prediction for BRCA1 and BRCA2 mutation carriers.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers.

Germline mutations in BRCA1 and BRCA2 confer high risks of female breast and ovarian cancer. However, there is strong evidence that these risks are modified by other factors, including familial or genetic factors. Genome-wide association studies have identified several breast cancer genetic susceptibility variants in the general population that are also associated with breast cancer risk for mu...

متن کامل

Genetic susceptibility to triple-negative breast cancer.

Triple-negative breast cancers (TNBC), defined by the absence of estrogen receptor, progesterone receptor, and HER-2 expression, account for 12% to 24% of all breast cancers. TNBC is associated with early recurrence of disease and poor outcome. Germline mutations in the BRCA1 and BRCA2 breast cancer susceptibility genes have been associated with up to 15% of TNBC, and TNBC accounts for 70% of b...

متن کامل

Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets and laptops at night

Breast cancer is the most common malignancy among women, both in the developed and developing countries. Women with mutations in the BRCA1 and BRCA2 genes have an increased risk of breast and ovarian cancers. Recent studies show that short-wavelength visible light disturb the secretion of melatonin and causes circadian rhythm disruption. We have previously studied the health effects of exposure...

متن کامل

جهش های ژنتیکی جدید در ژن های اصلی سرطان پستان (BRCA1/BRCA2) در زنان ایرانی مبتلا به سرطان پستان زودرس

Background: Breast cancer is the most common female malignancy and the main cause of death in  mid-aged women. Genetic germ line mutations in BRCAI/BRCA2 in Iranian women with breast or  ovarian cancer have not been yet reported. Materials and methods: Clinical data, family history and blood samples were obtained from 83  females aged less than 45 years with primary breast cancer in order to su...

متن کامل

Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women

Objective(s): Breast cancer is the most common cancer in women. Every year, one million new cases are reported worldwide, representing 18% of the total number of cancer in women. Hereditary BRCA1 and BRCA2 mutations account for about 60% of inherited breast cancer and are the only known causes of hereditary breast cancer syndrome. The aim of this study was to determine the frequency of BRCA2 (e...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

دوره 21 4  شماره 

صفحات  -

تاریخ انتشار 2012